Literature DB >> 25896132

Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells.

Katja Linher-Melville1, Sina Haftchenary, Patrick Gunning, Gurmit Singh.   

Abstract

System Xc- is a cystine/glutamate antiporter that contributes to the maintenance of cellular redox balance. The human xCT (SLC7A11) gene encodes the functional subunit of system Xc-. Transcription factors regulating antioxidant defense mechanisms including system Xc- are of therapeutic interest, especially given that aggressive breast cancer cells exhibit increased system Xc- function. This investigation provides evidence that xCT expression is regulated by STAT3 and/or STAT5A, functionally affecting the antiporter in human breast cancer cells. Computationally analyzing two kilobase pairs of the xCT promoter/5' flanking region identified a distal gamma-activated site (GAS) motif, with truncations significantly increasing luciferase reporter activity. Similar transcriptional increases were obtained after treating cells transiently transfected with the full-length xCT promoter construct with STAT3/5 pharmacological inhibitors. Knock-down of STAT3 or STAT5A with siRNAs produced similar results. However, GAS site mutation significantly reduced xCT transcriptional activity, suggesting that STATs may interact with other transcription factors at more proximal promoter sites. STAT3 and STAT5A were bound to the xCT promoter in MDA-MB-231 cells, and binding was disrupted by pre-treatment with STAT inhibitors. Pharmacologically suppressing STAT3/5 activation significantly increased xCT mRNA and protein levels, as well as cystine uptake, glutamate release, and total levels of intracellular glutathione. Our data suggest that STAT proteins negatively regulate basal xCT expression. Blocking STAT3/5-mediated signaling induces an adaptive, compensatory mechanism to protect breast cancer cells from stress, including reactive oxygen species, by up-regulating xCT expression and the function of system Xc-. We propose that targeting system Xc- together with STAT3/5 inhibitors may heighten therapeutic anti-cancer effects.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25896132     DOI: 10.1007/s11010-015-2412-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  71 in total

1.  MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11.

Authors:  Xiao-Xiao Liu; Xiao-Jun Li; Bo Zhang; Yong-Jun Liang; Ci-Xiang Zhou; Dan-Xia Cao; Ming He; Guo-Qiang Chen; Jian-Rong He; Qian Zhao
Journal:  FEBS Lett       Date:  2011-04-14       Impact factor: 4.124

2.  Transcriptional control of cystine/glutamate transporter gene by amino acid deprivation.

Authors:  Hideyo Sato; Shinobu Nomura; Kanako Maebara; Kanako Sato; Michiko Tamba; Shiro Bannai
Journal:  Biochem Biophys Res Commun       Date:  2004-12-03       Impact factor: 3.575

3.  Induction of cystine transport activity in human fibroblasts by oxygen.

Authors:  S Bannai; H Sato; T Ishii; Y Sugita
Journal:  J Biol Chem       Date:  1989-11-05       Impact factor: 5.157

4.  N-Acetylcysteine and allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes.

Authors:  Tingting Wang; Xiaowen Mao; Haobo Li; Shigang Qiao; Aimin Xu; Junwen Wang; Shaoqing Lei; Zipeng Liu; Kwok F J Ng; Gordon T Wong; Paul M Vanhoutte; Michael G Irwin; Zhengyuan Xia
Journal:  Free Radic Biol Med       Date:  2013-06-06       Impact factor: 7.376

5.  Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.

Authors:  R Garcia; T L Bowman; G Niu; H Yu; S Minton; C A Muro-Cacho; C E Cox; R Falcone; R Fairclough; S Parsons; A Laudano; A Gazit; A Levitzki; A Kraker; R Jove
Journal:  Oncogene       Date:  2001-05-03       Impact factor: 9.867

Review 6.  Reactive oxygen species in cell signaling.

Authors:  V J Thannickal; B L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-12       Impact factor: 5.464

7.  Inducers of oxidative stress block ciliary neurotrophic factor activation of Jak/STAT signaling in neurons.

Authors:  N Kaur; B Lu; R K Monroe; S M Ward; S W Halvorsen
Journal:  J Neurochem       Date:  2005-03       Impact factor: 5.372

8.  System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes.

Authors:  María Domercq; María Victoria Sánchez-Gómez; Catherine Sherwin; Estibaliz Etxebarria; Robert Fern; Carlos Matute
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

9.  Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteine.

Authors:  T Ishii; Y Sugita; S Bannai
Journal:  J Cell Physiol       Date:  1987-11       Impact factor: 6.384

10.  Current views of toll-like receptor signaling pathways.

Authors:  Masahiro Yamamoto; Kiyoshi Takeda
Journal:  Gastroenterol Res Pract       Date:  2010-12-14       Impact factor: 2.260

View more
  19 in total

Review 1.  xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling.

Authors:  Jinyun Liu; Xiaojun Xia; Peng Huang
Journal:  Mol Ther       Date:  2020-09-02       Impact factor: 11.454

Review 2.  Main path and byways: non-vesicular glutamate release by system xc(-) as an important modifier of glutamatergic neurotransmission.

Authors:  Ann Massie; Séverine Boillée; Sandra Hewett; Lori Knackstedt; Jan Lewerenz
Journal:  J Neurochem       Date:  2015-09-29       Impact factor: 5.372

Review 3.  System Xc-: a key regulatory target of ferroptosis in cancer.

Authors:  Man-Ru Liu; Wen-Tao Zhu; Dong-Sheng Pei
Journal:  Invest New Drugs       Date:  2021-01-27       Impact factor: 3.850

4.  Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Metabolism to Peripheral Sensory Pain Pathways.

Authors:  Jennifer Fazzari; Katja Linher-Melville; Gurmit Singh
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 5.  Amino Acid Transporters and Glutamine Metabolism in Breast Cancer.

Authors:  Yoon Jin Cha; Eun-Sol Kim; Ja Seung Koo
Journal:  Int J Mol Sci       Date:  2018-03-19       Impact factor: 5.923

Review 6.  The cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review).

Authors:  Joseph G Sinkovics
Journal:  Int J Oncol       Date:  2015-07-23       Impact factor: 5.650

7.  Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity.

Authors:  Katja Linher-Melville; Mina G Nashed; Robert G Ungard; Sina Haftchenary; David A Rosa; Patrick T Gunning; Gurmit Singh
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

8.  Inhibition of Prostaglandin Reductase 2, a Putative Oncogene Overexpressed in Human Pancreatic Adenocarcinoma, Induces Oxidative Stress-Mediated Cell Death Involving xCT and CTH Gene Expressions through 15-Keto-PGE2.

Authors:  Emily Yun-Chia Chang; Yi-Cheng Chang; Chia-Tung Shun; Yu-Wen Tien; Shu-Huei Tsai; Siow-Wey Hee; Ing-Jung Chen; Lee-Ming Chuang
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

9.  Functional effects of TrkA inhibition on system xC--mediated glutamate release and cancer-induced bone pain.

Authors:  Tanya Miladinovic; Robert G Ungard; Katja Linher-Melville; Snezana Popovic; Gurmit Singh
Journal:  Mol Pain       Date:  2018 Jan-Dec       Impact factor: 3.395

10.  Identification of a functional antioxidant response element at the HIF1A locus.

Authors:  Sarah E Lacher; Daniel C Levings; Samuel Freeman; Matthew Slattery
Journal:  Redox Biol       Date:  2018-08-30       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.